1. Interactions between and Shared Molecular Mechanisms of Diabetic Peripheral Neuropathy and Obstructive Sleep Apnea in Type 2 Diabetes Patients
   Hong Shen et al, 2018, Journal of Diabetes Research CrossRef
2. PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis
   Esraa M. Zakaria et al, 2017, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
3. Rodent models for diabetes
   Patil Rashmi et al, 2023, 3 Biotech CrossRef
4. Experimental approaches for induction of diabetes mellitus and assessment of antidiabetic activity: An in vitro and in vivo methodological review
   Shahin Gavanji et al, 2024, Fundamental & Clinical Pharmacology CrossRef
5. Experimental Diabetes Mellitus in Different Animal Models
   Amin Al-awar et al, 2016, Journal of Diabetes Research CrossRef
6. Identify the Key Active Ingredients and Pharmacological Mechanisms of Compound XiongShao Capsule in Treating Diabetic Peripheral Neuropathy by Network Pharmacology Approach
   Meixiang Yu et al, 2019, Evidence-Based Complementary and Alternative Medicine CrossRef
7. Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment
   Jinxi Zhu et al, 2024, Frontiers in Endocrinology CrossRef
8. Nicotinamide and Nicotinoyl-Gamma-Aminobutyric Acid as Neuroprotective Agents Against Type 1 Diabetes-Induced Nervous System Impairments in Rats
   Tamara Kuchmerovska et al, 2025, Neurochemical Research CrossRef
9. Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats
   Mykhailo M. Guzyk et al, 2016, Neurochemical Research CrossRef